Franco Paolorossi

1.4k total citations
41 papers, 1.1k citations indexed

About

Franco Paolorossi is a scholar working on Endocrine and Autonomic Systems, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Franco Paolorossi has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrine and Autonomic Systems, 14 papers in Pulmonary and Respiratory Medicine and 14 papers in Oncology. Recurrent topics in Franco Paolorossi's work include Circadian rhythm and melatonin (19 papers), Cancer-related cognitive impairment studies (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Franco Paolorossi is often cited by papers focused on Circadian rhythm and melatonin (19 papers), Cancer-related cognitive impairment studies (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Franco Paolorossi collaborates with scholars based in Italy, Switzerland and United States. Franco Paolorossi's co-authors include Paolo Lissoni, Gabriele Tancini, Sandro Barni, Antonio Ardizzoia, Sergio Crispino, Mario Mandalà, Massimo Vaghi, Fabio Malugani, A. Conti and R. Longarini and has published in prestigious journals such as Cancer, Annals of the New York Academy of Sciences and British Journal of Cancer.

In The Last Decade

Franco Paolorossi

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franco Paolorossi Italy 17 476 269 243 222 163 41 1.1k
Fabio Malugani Italy 17 379 0.8× 227 0.8× 111 0.5× 286 1.3× 85 0.5× 28 941
Sipra Saha Sweden 10 202 0.4× 127 0.5× 195 0.8× 405 1.8× 140 0.9× 13 1.5k
Yusuke Sagara Japan 20 320 0.7× 100 0.4× 154 0.6× 231 1.0× 77 0.5× 58 1.1k
Yutaka Uehara Japan 19 360 0.8× 177 0.7× 293 1.2× 361 1.6× 40 0.2× 60 1.2k
D.J.A. Eckland United Kingdom 18 222 0.5× 134 0.5× 136 0.6× 435 2.0× 66 0.4× 37 1.5k
Ana Guerra‐Librero Spain 17 387 0.8× 73 0.3× 229 0.9× 486 2.2× 89 0.5× 25 1.1k
Uwe Pfeil Germany 24 109 0.2× 132 0.5× 235 1.0× 823 3.7× 220 1.3× 54 1.5k
Xiaohong Cai China 23 190 0.4× 108 0.4× 249 1.0× 562 2.5× 152 0.9× 53 1.3k
Verónica Nin United States 17 98 0.2× 331 1.2× 425 1.7× 645 2.9× 36 0.2× 25 1.8k
Ángel Carazo Spain 16 236 0.5× 62 0.2× 207 0.9× 401 1.8× 20 0.1× 36 965

Countries citing papers authored by Franco Paolorossi

Since Specialization
Citations

This map shows the geographic impact of Franco Paolorossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franco Paolorossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franco Paolorossi more than expected).

Fields of papers citing papers by Franco Paolorossi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franco Paolorossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franco Paolorossi. The network helps show where Franco Paolorossi may publish in the future.

Co-authorship network of co-authors of Franco Paolorossi

This figure shows the co-authorship network connecting the top 25 collaborators of Franco Paolorossi. A scholar is included among the top collaborators of Franco Paolorossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franco Paolorossi. Franco Paolorossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giani, Luisa, Sofia Meregalli, Massimo Vaghi, et al.. (2000). Five-Year Survival Results of Subcutaneous Low-Dose Immunotherapy with Interleukin-2 Alone in Metastatic Renal Cell Cancer Patients. Urologia Internationalis. 64(1). 3–8. 29 indexed citations
2.
Lissoni, Paolo, Sandro Barni, Mario Mandalà, et al.. (1999). Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. European Journal of Cancer. 35(12). 1688–1692. 208 indexed citations
3.
Lissoni, Paolo, Gabriele Tancini, Franco Paolorossi, et al.. (1999). Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low‐dose epirubicin plus melatonin: A phase II study. Journal of Pineal Research. 26(3). 169–173. 39 indexed citations
4.
Lissoni, Paolo, Luca Fumagalli, Franco Paolorossi, & Mario Mandalà. (1999). Changes in Lymphocyte Number during Cancer Chemotherapy and Their Relation to Clinical Response. The International Journal of Biological Markers. 14(2). 115–117. 11 indexed citations
5.
Lissoni, Paolo, Gabriele Tancini, Sandro Barni, et al.. (1997). Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin. Supportive Care in Cancer. 5(2). 126–129. 79 indexed citations
7.
Lissoni, Paolo, Franco Paolorossi, Gabriele Tancini, et al.. (1996). A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients. British Journal of Cancer. 74(9). 1466–1468. 44 indexed citations
8.
Lissoni, Paolo, Franco Paolorossi, Gabriele Tancini, et al.. (1996). Is there a role for melatonin in the treatment of neoplastic cachexia?. European Journal of Cancer. 32(8). 1340–1343. 96 indexed citations
9.
Lissoni, Paolo, et al.. (1996). The pineal hormone melatonin in hematology and its potential efficacy in the treatment of thrombocytopenia.. PubMed. 87(12). 582–5. 18 indexed citations
10.
Lissoni, Paolo, Sandro Barni, Antonio Ardizzoia, et al.. (1994). Prognostic Factors of the Clinical Response to Subcutaneous Immunotherapy with lnterleukin-2 Alone in Patients with Metastatic Renal Cell Carcinoma. Oncology. 51(1). 59–62. 38 indexed citations
11.
Barni, Sandro, et al.. (1993). A Weekly Schedule of Epirubicin in Pretreated Advanced Breast Cancer. Tumori Journal. 79(1). 45–48. 9 indexed citations
12.
Lissoni, Paolo, Sandro Barni, Antonio Ardizzoia, et al.. (1992). Second line therapy with low-dose subcutaneous interleukin-2 alone in advanced renal cancer patients resistant to interferon-alpha. European Journal of Cancer. 28(1). 92–96. 42 indexed citations
13.
14.
Tancini, Gabriele, Sandro Barni, Sergio Crispino, Franco Paolorossi, & Paolo Lissoni. (1989). A Study of Thyroid Function in Cancer Cachexia. Tumori Journal. 75(2). 185–188. 7 indexed citations
15.
Esposti, G., D. Esposti, Sandro Barni, et al.. (1988). A study on the relationship between the pineal gland and the opioid system in patients with cancer preliminary considerations. Cancer. 62(3). 494–499. 13 indexed citations
16.
Barni, Sandro, et al.. (1987). Anal Squamous Cell Carcinoma Arising on Radio-Dermatitis Cured with Chemotherapy Alone: Case Report. Tumori Journal. 73(4). 423–424. 1 indexed citations
17.
Barni, Sandro, Paolo Lissoni, Gabriele Tancini, et al.. (1987). Acute Effects of Various Chemotherapeutic Combinations on Hypophyseal and Pineal Hormone Secretions in Cancer Patients. Tumori Journal. 73(2). 181–185. 7 indexed citations
18.
Lissoni, Paolo, Sandro Barni, Gabriele Tancini, et al.. (1987). Evaluation of the pineal function in patients affected by solid tumor. Journal of Steroid Biochemistry. 28. 171–171. 1 indexed citations
19.
Colombo, A, Sergio Crispino, Sandro Barni, et al.. (1987). [Concomitant therapy with cisplatin and radiotherapy in locally advanced tumors of the cervico-facial area].. PubMed. 74(4). 334–7.
20.
Barni, Sandro, Paolo Lissoni, Franco Paolorossi, et al.. (1987). Effects of radical mastectomy on prolactin blood levels in patients with breast cancer. European Journal of Cancer and Clinical Oncology. 23(8). 1141–1145. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026